TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 201 filers reported holding TG THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $360,373 | +27.6% | 23,961 | +0.4% | 0.02% | +15.8% |
| Q4 2022 | $282,370 | +107.6% | 23,869 | +3.8% | 0.02% | +111.1% |
| Q3 2022 | $136,000 | +24.8% | 22,986 | -10.6% | 0.01% | +50.0% |
| Q2 2022 | $109,000 | -42.0% | 25,715 | +30.1% | 0.01% | -40.0% |
| Q1 2022 | $188,000 | -37.3% | 19,772 | +25.2% | 0.01% | -44.4% |
| Q4 2021 | $300,000 | +35.1% | 15,787 | +136.4% | 0.02% | +50.0% |
| Q3 2021 | $222,000 | -64.6% | 6,679 | -58.8% | 0.01% | -64.7% |
| Q2 2021 | $628,000 | +76.4% | 16,196 | +119.5% | 0.03% | +70.0% |
| Q1 2021 | $356,000 | – | 7,380 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
| Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
| 683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
| MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
| Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
| Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
| PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
| Antara Capital LP | 900,000 | $3,825,000 | 0.16% |